Article
Curcumin induces human cathelicidin antimicrobial peptide gene expression through a vitamin D receptor-independent pathway.
Linus Pauling Institute, Oregon State University, Corvallis, OR 97331, USA; Department of Biochemistry and Biophysics, Oregon State University, Corvallis, OR 97331, USA.
The Journal of nutritional biochemistry (impact factor:
4.29).
07/2012;
DOI:10.1016/j.jnutbio.2012.04.002
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: The possible roles of vitamin D and curcumin in treating gonorrhea.
[show abstract] [hide abstract]
ABSTRACT: Drug-resistant gonorrhea, Neisseria gonorrhoeae (N. gonorrhoeae), is an emerging concern, especially because the risk of bladder cancer is associated with this infection. N. gonorrhoeae suppresses T-helper 1(Th1) and Th2 responses and enhances Th17 responses via a mechanism involving transforming growth factor-beta (TGF-β) and regulatory T cells. Blockade of TGF-β alleviates the suppression of specific anti-gonococcal responses and allows Th1 and Th2 responses to emerge with concomitant boosting of immune memory and protective immunity. Gonorrhea activates nuclear factor kappaB (NF-kappaB), which plays a critical role in signal-transduction pathways involved in inflammation. The innate immune system can eventually clear gonorrhea. Vitamin D is emerging as a potential, powerful, anti-microbial agent with these effects: it supports the innate immune system in combating bacterial infections; it decreases levels of TGF-β and NF-kappaB activation; and it induces production of LL-37 (cathelicidin), which has antimicrobial and antiendotoxin properties. In addition, via an independent vitamin D receptor pathway, curcumin also induces LL-37 production, inhibiting N. gonorrhoeae-induced NF-kappaB signaling and inducing autophagy. Therefore, vitamin D and curcumin taken together may be useful in combating both normal and drug-resistant gonorrhea. Moreover, the possible synergy between these two agents in improving outcomes is worthy of additional investigation.Medical Hypotheses 04/2013; · 1.39 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
chromatin immunoprecipitation assays
Curcumin treatment induced CAMP promoter activity
curcumin up-regulated CAMP mRNA
CYP24A1 mRNA expression
human cathelicidin antimicrobial peptide
increase binding
induce CAMP
keratinocyte cell line HaCaT
luciferase reporter
pleiotropic biologic effects
polyunsaturated fatty acids
potential ligands
protein levels
three cell lines
VDR
VDR binding site
VDR target genes
vitamin D receptor
vitamin D receptor-independent manner
vitro studies